Phase I study of pembrolizumab in combination with ibrutinib for the treatment of unresectable or metastatic melanoma - Yao, Yuan; Yan, Yiyi; Suman, Vera J.; Dietz, Allan B.; Erskine, Courtney L.; Dimou, Anastasios; Markovic, Svetomir N.; McWilliams, Robert R.; Montane, Heather N.; Block, Matthew S. (Frontiers in Immunology, 2025)